Have never owned a pre-approval biotech that acts like this one and have owned many. No one can explain the drop from 30's to here to my satisfaction and the continued dump at IMO a laughable valuation continues disturb and trouble me. At 15 I bought more on the assumption that if nothing else works EXCEPT cosmetics, it's still way undervalued.
What's transpired since 15 print has shaken me to the core - how could I be THIS wrong??? What am I missing?? I would normally average down again but I'm drowning and that strategy has been a horrible failure up until now. Simply don't trust this anymore stock and have no idea what to do with it
Probably not. 75% of EOLS earnings came from competitors with the rest being tx naive customers. IMO, this is encouraging - AGN doesn't have its customers locked in to the extent that I'd expected; and there's substantial growth in the cosmetic market at least.
I'd speculate that a biotech without an approved product would be more susceptible to market moves than one which is already profitable; and the IP question may not be fully resolved in everyone's mind.
or you may be right. there's bad news coming down the pipe. ;)
Market Data 
Markets 
